Therapeutic Advances in Neurological Disorders

Scope & Guideline

Advancing knowledge for a brighter neurological future.

Introduction

Welcome to the Therapeutic Advances in Neurological Disorders information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Therapeutic Advances in Neurological Disorders, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1756-2856
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2008 to 2024
AbbreviationTHER ADV NEUROL DISO / Ther. Adv. Neurol. Disord.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Neurological Disorders' focuses on advancing the understanding and treatment of neurological disorders through innovative research, clinical studies, and reviews. Its aims and scopes are characterized by a multidisciplinary approach that encompasses various facets of neurology, from basic science to clinical applications.
  1. Neurological Disorders Research:
    The journal emphasizes research related to a wide range of neurological disorders, including multiple sclerosis, Parkinson's disease, epilepsy, and neuromuscular disorders. It aims to provide insights into the pathophysiology, diagnosis, and treatment of these conditions.
  2. Clinical Trials and Efficacy Studies:
    A significant focus is on clinical trials evaluating the efficacy and safety of therapeutic interventions. The journal publishes systematic reviews and meta-analyses that synthesize evidence from clinical studies to guide treatment decisions.
  3. Innovative Therapeutic Approaches:
    The journal explores novel therapeutic strategies, including pharmacological treatments, immunotherapies, and emerging technologies such as gene therapy and neurostimulation techniques.
  4. Multidisciplinary Collaboration:
    There is a strong emphasis on collaboration among various specialties within neurology, combining insights from clinical practice, basic research, and patient-centered care to advance treatment paradigms.
  5. Patient-Centric Research:
    The journal prioritizes studies that consider patient perspectives, treatment adherence, and quality of life, reflecting a commitment to improving patient outcomes in neurological disorders.
Recent publications in 'Therapeutic Advances in Neurological Disorders' highlight several emerging themes that reflect current trends in neurological research and clinical practice. These themes indicate a shift towards more innovative and patient-centered approaches to treatment.
  1. Precision Medicine in Neurology:
    An increasing number of studies focus on precision medicine approaches, tailoring treatments based on individual patient characteristics such as genetic profiles and biomarkers. This trend is indicative of a broader movement towards personalized healthcare.
  2. Neuroinflammation and Immune Modulation:
    Research on neuroinflammation and its role in various neurological disorders is gaining prominence, with a focus on immune modulation therapies. This reflects a growing understanding of the immune system's impact on neurological health.
  3. Digital Health and Telemedicine:
    The integration of digital health technologies and telemedicine in managing neurological disorders is trending, particularly following the COVID-19 pandemic. Studies exploring the effectiveness of remote monitoring and treatment are becoming more common.
  4. Real-World Evidence and Patient Registries:
    There is a significant increase in the use of real-world evidence and patient registries to inform treatment patterns and outcomes. This trend emphasizes the importance of understanding how therapies perform in everyday clinical settings.
  5. Machine Learning and Artificial Intelligence:
    The application of machine learning and AI in predicting outcomes and personalizing treatment plans for neurological disorders is emerging as a significant area of research, reflecting the intersection of technology and medicine.

Declining or Waning

While 'Therapeutic Advances in Neurological Disorders' continues to evolve, certain themes have shown a decline in prominence in recent years. This waning focus may reflect shifts in clinical priorities, funding availability, or emerging areas of interest that have overshadowed older topics.
  1. Traditional Pharmacotherapy:
    There has been a noticeable decline in publications focusing solely on traditional pharmacotherapy for neurological disorders, possibly due to the increasing interest in novel therapies and personalized medicine.
  2. Basic Science Studies:
    Research articles centered exclusively on basic science without direct clinical implications have decreased, as the journal shifts toward more translational research that bridges laboratory findings with clinical applications.
  3. Single-Center Studies:
    The prevalence of single-center observational studies has waned, likely due to a preference for multi-center collaborations that enhance the generalizability of findings and provide a broader patient perspective.
  4. Historical Perspectives:
    There is less emphasis on historical reviews of treatments and practices in neurology, as the focus has moved towards current innovations and future directions in therapeutic approaches.
  5. Focus on Rare Disorders:
    The journal appears to have reduced its emphasis on rare neurological disorders, potentially due to the limited available research and funding compared to more prevalent conditions.

Similar Journals

Neurology Research International

Pioneering Open Access in Neurology Research
Publisher: HINDAWI LTDISSN: 2090-1852Frequency:

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

Neurology-Neuroimmunology & Neuroinflammation

Championing open access to critical neuroimmunology findings.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2332-7812Frequency: 6 issues/year

Neurology-Neuroimmunology & Neuroinflammation, published by LIPPINCOTT WILLIAMS & WILKINS, stands at the forefront of research in the rapidly evolving fields of neurology and neuroimmunology. Since its inception in 2014, this prestigious journal has embraced an Open Access model, ensuring that groundbreaking findings are readily available to researchers, clinicians, and students worldwide. Covering a broad spectrum of topics related to neuroinflammation, the journal has gained a remarkable reputation, attaining a Q1 ranking in both Neurology and Neurology (clinical) as of 2023, and ranking #6 out of 192 in the neuroscience category on Scopus. The journal's commitment to high-quality research aims to facilitate the understanding of neurological disorders, promote innovative therapies, and inspire collaboration among professionals. Addressing critical issues at the intersection of neurology, immunology, and clinical practice, Neurology-Neuroimmunology & Neuroinflammation is an essential platform for the dissemination of knowledge and the advancement of this vital field.

JAMA Neurology

Shaping the Future of Neurology One Article at a Time
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Seminars in Pediatric Neurology

Advancing knowledge in pediatric neurology.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1071-9091Frequency: 4 issues/year

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

Therapeutic Advances in Psychopharmacology

Advancing the Frontiers of Mental Health Treatment
Publisher: SAGE PUBLICATIONS LTDISSN: 2045-1253Frequency: 1 issue/year

Therapeutic Advances in Psychopharmacology is a leading open-access journal published by SAGE Publications Ltd, focusing on the dynamic integration of pharmacological therapies and psychological health. Since its inception in 2011, this journal has made a significant impact on the fields of pharmacology and psychiatry, consistently earning a Q1 ranking in both categories as of 2023, reflecting its esteemed position within the scientific community. With an impressive Scopus rank placing it in the top 15% across relevant disciplines, the journal serves as a vital platform for researchers, professionals, and students eager to explore cutting-edge advancements in psychopharmacology. The open-access model, established in 2019, ensures that groundbreaking research is accessible to a wide audience, fostering collaboration and innovation in therapeutic strategies for mental health disorders. Through the dissemination of high-quality research and reviews, Therapeutic Advances in Psychopharmacology is committed to advancing understanding and practice within this critical field.

NEUROLOGIC CLINICS

Connecting research and clinical excellence in neurology.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Expert Review of Neurotherapeutics

Pioneering Innovations for Neurological Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7175Frequency: 12 issues/year

Expert Review of Neurotherapeutics is an esteemed journal published by Taylor & Francis Ltd, focusing on the rapidly evolving field of neurotherapeutics. With an ISSN of 1473-7175 and an E-ISSN of 1744-8360, this publication aims to bridge the gap between clinical and preclinical research, providing a platform for innovative therapeutic strategies in neurology and neuroscience. The journal boasts impressive impact factor rankings, categorized as Q2 in both clinical neurology and miscellaneous neuroscience, and Q1 in medical pharmacology for 2023. Its reputable placement in Scopus rankings, including Rank #82/400 in clinical neurology, underscores its significance within the medical research community. Spanning from 2001 to 2024, the journal publishes critical reviews and original research articles aimed at enhancing understanding and treatment in neurological disorders. Although it currently does not offer open access, articles published in the journal are crucial for researchers, healthcare professionals, and students seeking to stay at the forefront of advancements in neurotherapeutics. With its strong emphasis on rigorous peer-reviewed content, Expert Review of Neurotherapeutics continues to be a vital resource for those dedicated to improving patient outcomes in the realm of neurology.

Degenerative Neurological and Neuromuscular Disease

Fostering collaboration for a healthier nervous system.
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.

Archives of Neuroscience

Exploring the depths of brain function and disorders.
Publisher: BRIEFLANDISSN: 2322-3944Frequency: 4 issues/year

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Physiotherapy

Fostering Excellence in Physiotherapy Scholarship
Publisher: ELSEVIER SCI LTDISSN: 0031-9406Frequency: 4 issues/year

Physiotherapy, published by Elsevier Science Ltd, stands as a prestigious journal in the field of Physical Therapy, Sports Therapy, and Rehabilitation. Since its inception in 1945, this journal has been committed to advancing the practice and science of physiotherapy through rigorous peer-reviewed research, making significant contributions to both clinical practice and academia. With an impressive Q1 ranking and a Scopus percentile of 88th, it is widely regarded as a leading source of evidence-based information for professionals and researchers alike. The journal operates without an Open Access option, which ensures that it maintains the quality and integrity of the research it publishes while providing exclusive access to valuable insights for its subscribers. By focusing on diverse topics within its scope, including therapeutic techniques, rehabilitation strategies, and sports medicine, Physiotherapy continues to shape the future of physiotherapy practice and education, making it an essential resource for anyone invested in this dynamic field.